Clinical Trials on Mixed Dyslipidemia
Total 3922 results
-
NeuroBo Pharmaceuticals Inc.CompletedSevere Hypertriglyceridemia | Mixed DyslipidaemiaUnited States, Canada
-
GlaxoSmithKlineCompletedDyslipidaemia | DyslipidaemiasGermany, Estonia, Belgium, France, Netherlands, Denmark, Portugal, Norway, Sweden, Lithuania, Finland
-
Addpharma Inc.Recruiting
-
University of GuadalajaraCompleted
-
AbbottCompletedMixed DyslipidemiaUnited States
-
Hanlim Pharm. Co., Ltd.RecruitingMixed DyslipidemiaKorea, Republic of
-
IlDong Pharmaceutical Co LtdNot yet recruiting
-
Arrowhead PharmaceuticalsCompletedMixed DyslipidemiaUnited States, Australia, Poland, New Zealand, Canada, Hungary
-
Provident Clinical ResearchReliant PharmaceuticalsCompleted
-
Arrowhead PharmaceuticalsActive, not recruitingMixed DyslipidemiaUnited States, Australia, Canada, New Zealand
-
Provident Clinical ResearchReliant PharmaceuticalsUnknown
-
GlaxoSmithKlineCompletedHealthy Subjects | Dyslipidaemia | DyslipidaemiasUnited Kingdom
-
IlDong Pharmaceutical Co LtdCompletedMixed DyslipidemiasKorea, Republic of
-
Merck Sharp & Dohme LLCTerminatedHypercholesterolemia | Mixed Dyslipidemia
-
Kowa Research Institute, Inc.CompletedMixed Dyslipidemia | Primary DyslipidemiaUnited States
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyRecruitingHypercholesterolemia | Mixed DyslipidemiaAustria, United Kingdom, Italy, Germany, Belgium
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyDaiichi Sankyo GermanyCompleted
-
NovartisCompletedHypercholesterolemia | Mixed DyslipidemiaChina
-
AbbottCompletedHyperlipidemia | Mixed DyslipidemiaUnited States
-
Novartis PharmaceuticalsNot yet recruitingMixed Dyslipidemia | Primary Hypercholesterolemia
-
Boryung Pharmaceutical Co., LtdRecruitingMixed Dyslipidemia | Primary HypercholesterolemiaKorea, Republic of
-
Merck Sharp & Dohme LLCCompletedMixed Dyslipidemia | Primary Hypercholesterolemia
-
Merck Sharp & Dohme LLCCompletedMixed Dyslipidemia | Primary Hypercholesterolemia
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyWithdrawnMixed Dyslipidemia | Primary Hypercholesterolemia
-
AmgenTerminatedMixed Dyslipidemia | Primary HypercholesterolemiaChina
-
AmgenCompletedMixed Dyslipidemia | Primary HypercholesterolemiaUnited States, Canada
-
Merck Sharp & Dohme LLCTerminatedMixed Dyslipidemia | Primary Hypercholesterolemia
-
Orient Pharma Co., Ltd.CompletedPrimary Hypercholesterolemia | Mixed DyslipidemiasTaiwan, Australia, New Zealand
-
Novartis PharmaceuticalsRecruitingMixed Dyslipidemia | Primary HypercholesterolemiaSwitzerland, Saudi Arabia, United Arab Emirates, United Kingdom, Austria, Israel, China, Malaysia
-
Novartis PharmaceuticalsRecruitingMixed Dyslipidemia | Primary HypercholesterolemiaChina
-
Merck Sharp & Dohme LLCTerminatedMixed Dyslipidemia | Primary Hypercholesterolemia
-
AmgenCompletedMixed Dyslipidemia | Primary HypercholesterolemiaUnited States, Canada
-
AmgenCompletedHyperlipidemia and Mixed DyslipidemiaUnited States, Canada, Denmark, France, Italy, Belgium, Czechia, Taiwan, Japan, Switzerland, Germany, United Kingdom, Korea, Republic of, Hong Kong, Netherlands, New Zealand, South Africa, Australia, Spain, Austria, Hungary, Russian... and more
-
Shanghai Junshi Bioscience Co., Ltd.Not yet recruitingPrimary Hypercholesterolaemia and Mixed DyslipidemiaChina
-
Novartis PharmaceuticalsActive, not recruitingPrimary Hypercholesterolemia or Mixed DyslipidemiaChina
-
AmgenCompletedPrimary Hyperlipidemia and Mixed DyslipidemiaAustralia
-
PfizerWithdrawnPrimary Hyperlipidemia or Mixed DyslipidemiaChina
-
Misr University for Science and TechnologyActive, not recruiting
-
SanofiCompletedAtherosclerotic Cardiovascular Disease | Primary Hypercholesterolaemia and Mixed DyslipidaemiaGermany
-
Xention LtdCompleted
-
AstraZenecaCompletedDyslipidaemiaCzech Republic
-
AstraZenecaCompleted
-
Novartis PharmaceuticalsCompletedDyslipidaemiaJordan, United States, Taiwan
-
AmgenCompletedDiabetes, Hyperlipidemia, Mixed DyslipidemiaUnited States, Canada, France, Korea, Republic of, China, Argentina, Russian Federation, Colombia, Turkey, Brazil
-
AmgenCompletedHyperlipidemia or Mixed Dyslipidemia at High Risk for Cardiovascular EventsJapan
-
GlaxoSmithKlineCompletedDyslipidemias | DyslipidaemiasUnited States
-
GlaxoSmithKlineCompletedDyslipidaemiasUnited States, Canada
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted